CryoCell International Inc (CCEL) Stock Analysis

CryoCell International Inc (CCEL) is a publicly traded company in the HEALTHCARE sector. It trades at $3.53, carries a market capitalization of $28.60M. This page summarizes the public market data, fundamentals, and frequently asked questions for CCEL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL CARE FACILITIES

Exchange: NYSE MKT

Key Metrics

• Price: $3.53
• Market Cap: $28.60M
• EPS: $-0.32
• 52-Week High: $6.35
• 52-Week Low: $2.72

Market Sentiment

CryoCell International Inc currently has a Neutral sentiment score of -0.14.

About CryoCell International Inc

Cryo-Cell International, Inc. (CCEL) stands at the forefront of the biotechnology sector, offering advanced cell processing and cryogenic storage solutions that specialize in the preservation of umbilical cord blood stem cells for family use. Headquartered in Oldsmar, Florida, the company has garnered a reputation for its commitment to scientific innovation and exceptional customer service, catering to a market increasingly focused on the long-term health benefits associated with stem cell ba...

GNG Research Analysis

GNG Research scores CryoCell International Inc (CCEL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CCEL.

Frequently Asked Questions

Does CCEL pay dividends?

CryoCell International Inc (CCEL) does not currently pay a regular dividend.

What is CCEL's market cap?

CryoCell International Inc (CCEL) has a market capitalization of $28.60M with a current stock price of $3.53.